(DCPH) – Corporate News
-
Deciphera Pharmaceuticals (DCPH) Presents Long-Term Follow-Up Results from INTRIGUE Phase 3 Clinical Study in Second-Line GIST Patients
-
Deciphera Pharmaceuticals (DCPH) and GENESIS Pharma Enter an Exclusive Distribution Agreement to Commercialize RIPRETINIB in 14 EU Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to DCPH Stock Lookup